Ellingsen P A
Acta Psychiatr Scand. 1983 Mar;67(3):154-8. doi: 10.1111/j.1600-0447.1983.tb00336.x.
In a double-blind, cross-over trial, triazolam (0.5 mg) was compared with nitrazepam (5 mg) in patients with disturbed sleep. Each drug was given once, with a 48-h interval, to 40 outpatients. Quality, duration, and latency of sleep, and number of awakenings during the night, showed a significant difference in favour of triazolam. An overall evaluation of sleep also showed triazolam to be superior to nitrazepam. Both drugs seemed to reduce dream activity and to alter the character of the dreams. There was no significant difference in side effects.
在一项双盲交叉试验中，对40名门诊睡眠障碍患者使用三唑仑（0.5毫克）和硝西泮（5毫克）进行比较。每种药物各服用一次，间隔48小时。睡眠质量、时长、潜伏期以及夜间觉醒次数方面，三唑仑均有显著优势。整体睡眠评估也显示三唑仑优于硝西泮。两种药物似乎都能减少梦境活动并改变梦的特征。副作用方面无显著差异。
